SEPTInvestingStart Free

FATE 10-Q: SEC filing

Fate Therapeutics

Filed with the SEC on · accession 0001193125-26-448543

FATE filed a 10-Q (quarterly report) with the SEC on Nov 5, 2026. Fate Therapeutics filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial results and operational updates. The stock moved -11.5% by the first close after the filing.

Summary of the filing

Fate Therapeutics filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial results and operational updates. The filing includes details on cash position, research and development expenses, and collaboration agreements.

For details, click here →How to read a 10-Q →

Key details

FilerFate Therapeutics Inc
Collaboration partnerOno Pharmaceutical Co Ltd
License partnerMemorial Sloan Kettering Cancer Center

How FATE stock reacted

Close before

$2.09

Nov 4, 2026

First close after

-11.48%

$1.85

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for FATE, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for FATE?

Click here

Frequently asked questions

What did FATE file with the SEC on Nov 5, 2026?

FATE filed a 10-Q (SEC filing). Fate Therapeutics filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial results and operational updates. The filing includes details on cash position, research and development expenses, and collaboration agreements.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did FATE stock react to this filing?

FATE closed at $2.09 before the filing and $1.85 on Nov 5, 2026 (-11.48%).

Other FATE SEC filings

Get alerts when FATE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
FATE overviewFATE analysisFATE newsLatest SEC filings